Tekla Life Sciences Stock Statistic Functions Linear Regression Slope
| HQL Stock | USD 16.69 0.01 0.06% |
| Symbol |
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Slope is the rate of change in Tekla Life Sciences price series over its benchmark or peer price series.
Tekla Life Technical Analysis Modules
Most technical analysis of Tekla Life help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Tekla from various momentum indicators to cycle indicators. When you analyze Tekla charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Tekla Life Sciences Investors
The stock is still going through the normal trading activities.Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange. The profile for Tekla Life integrates fundamentals, price behavior, and sector exposure. Defensive traits reduce macro sensitivity. Tekla Life has a market cap of 495.78 M, P/E of 2.84, ROE of 17.59%. 
Raphi Shpitalnik ยท Junior Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Tekla Life Sciences is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Tekla (USA Stocks:HQL) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs are aggregated from public filings and market reference sources and public institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Certain values may not reflect real-time changes. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Tekla Life Sciences may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Tekla Stock is Curated By:
Raphi Shpitalnik ยท Junior Member of Macroaxis Editorial BoardLearn to be your own money manager
Tracking Tekla Life inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Tekla Life Sciences pair trading
Pair trading with Tekla Life can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Tekla Life Pair Trading
Tekla Life Sciences Pair Trading Analysis
The wash-sale rule makes correlation analysis essential when harvesting losses on Tekla Life Sciences. Without a viable substitute for Tekla Life, investors may need to accept significant portfolio drift or forgo the tax benefit entirely.
The correlation matrix including Tekla Life quantifies the statistical co-movement between multiple assets simultaneously. Portfolio managers use this matrix to identify redundant positions and find instruments that genuinely complement a holding in Tekla Life Sciences.
Correlation analysis and pair evaluation for Tekla Life can support hedging context. The view can be extended across sectors or other related groups.More Resources for Tekla Stock Analysis
Reviewing Tekla Life Sciences commonly begins with financial statements and performance trends. Ratio context helps frame profitability, efficiency, and growth trends for Tekla Life Sciences Stock. Key reports that frame Tekla Life Sciences Stock are listed below:Tekla Life has a market cap of 495.78 M, operating margin of -3.47%, ROE of 17.59%. See Risk vs Return Analysis for portfolio-level analysis. This suggests a position in Tekla Life Sciences in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. Analysis related to Tekla Life should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Quarterly Earnings Growth 2.594 | Dividend Share 1.82 | Earnings Share 2.79 | Revenue Per Share | Quarterly Revenue Growth -0.70 |
Understanding Tekla Life Sciences includes distinguishing between market value and book value, where book value reflects Tekla accounting equity. Tekla Life's market capitalization is 495.78 M. A P/B ratio of 0.97 suggests Tekla Life trades near or below book value. Enterprise value stands at 495.7 M. Intrinsic value is an analytical estimate of Tekla Life's underlying worth that can differ from price and book value. Valuation methods help interpret those gaps.
The concept of value for Tekla Life differs from its quoted price, since each reflects a different lens. For Tekla Life, key inputs include a P/E ratio of 2.84, a P/B ratio of 0.97, a profit margin of 44.16%, and ROE of 17.59%. The quoted price is simply the exchange level where supply meets demand.